PROTAC IKKbeta degrader-1 is a IKKbeta PROTAC degrader (DC50 = 7.15 µM). PROTAC IKKbeta degrader-1 induces apoptosis (Apoptosis) in triple-negative breast cancer cells. PROTAC IKKbeta degrader-1 induces G1 phase cell cycle arrest in triple-negative breast cancer cells. PROTAC IKKbeta degrader-1 exhibits antiproliferative activity against a variety of cells. PROTAC IKKbeta degrader-1 is applicable for research related to cancers such as triple-negative breast cancer, colon cancer, liver cancer, pancreatic cancer[1].
Molekulargewicht:
690.78
Formel:
C37H46N4O9
Target-Kategorie:
Apoptosis,IKK,PROTACs
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
